Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

FDA stated that it

agreed with the design and planned analysis proposed by OncoGenex,

and that the study design adequately addresses the objectives

necessary to support a regulatory submission.

- Sonus signed an exclusive in-licensing agreement with Bayer

HealthCare LLC for development of a family of compounds known as

caspase activators presently in preclinical research. As the caspase

family of proteases plays essential roles in apoptosis, the caspase

activators offer the potential for the development of therapies in

the treatment of various cancers.

- OncoGenex received Fast Track designation from the FDA for

development of OGX-011 in combination with docetaxel for progressive

metastatic prostate cancer. Fast Track designation was granted on the

basis that OGX-011 may provide a significant improvement in the

safety or effectiveness of the treatment for a serious or life-

threatening disease. Based on this designation, the FDA will take

actions as appropriate to expedite the development and review of OGX-

011 for approval. These actions include scheduled meetings to obtain

FDA input into development plans, the option of submitting a New Drug

Application in sections rather than all components simultaneously,

and the option of requesting evaluation of studies using surrogate

endpoints.

- On October 7, 2008 OncoGenex and the FDA concluded a meeting whereby

the FDA agreed that "durable pain palliation is an acceptable and

desirable study endpoint" to support a product marketing approval for

OGX-011 as a treatment for hormone refractory prostate cancer (HRPC).

In addition, the FDA provided guidance on the submitted protocol

including recommendations on study endpoints, the appropriate patient

pop
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 1000 balances – 4 ... on customers’ weighing needs and expertly narrows down the ... balances, scales or even terminals. , First, select ... weight (or select readability instead) and define the accuracy ... selection criteria narrows down the list to models that ...
(Date:7/24/2014)... Draper University, a top program ... announce that for 6 weeks this summer, 39 ... on the Draper University campus in the heart ... focused on entrepreneurship, building real-world skills, and “learning ... its sixth cohort, continues to refresh its curriculum ...
(Date:7/24/2014)... July 24, 2014   Cypher Genomics, Inc., ... appointment of Adam Simpson as president ... rapid and comprehensive annotation and interpretation of individual ... "Cypher,s technology has the potential to ... enhancing diagnostic accuracy, optimizing therapeutic approaches and reducing ...
(Date:7/24/2014)... San Diego, CA (PRWEB) July 24, 2014 ... in the reporting of molecular diagnostic test results. ... tracking capabilities necessary for the validation and reporting ... in oncology. Molecular diagnostics is a rapidly growing ... for infectious disease, genetic predisposition, cancer, and companion ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2
... - Non-GAAP and GAAP Operating Earnings ... Diluted EPS Up 15%, GAAP Diluted EPS Up 16%, PALO ALTO, ... revenues of $237.4,million, representing an increase of 8.9% over revenues of $217.9 ... growth in sales of products for both life science and industrial,(which includes ...
... Jan. 23 PPD, Inc. (Nasdaq:,PPDI) today announced ... services,into China through an exclusive agreement with Peking ... PPD to begin,immediately providing biopharmaceutical clients with its ... China., "Chinese law makes it extremely difficult ...
... - Increases medical waste disposal capacity and capabilities to facilitate ... growth plans - New state-of-the-art autoclave technology provides environmentally ... operation, - With the addition of the autoclave, one of approximately ten permitted,commercial disposal facilities in the country ... of medical waste ...
Cached Biology Technology:Varian, Inc. Reports First Quarter 2008 Results 2Varian, Inc. Reports First Quarter 2008 Results 3Varian, Inc. Reports First Quarter 2008 Results 4Varian, Inc. Reports First Quarter 2008 Results 5Varian, Inc. Reports First Quarter 2008 Results 6Varian, Inc. Reports First Quarter 2008 Results 7Varian, Inc. Reports First Quarter 2008 Results 8Varian, Inc. Reports First Quarter 2008 Results 9Varian, Inc. Reports First Quarter 2008 Results 10Varian, Inc. Reports First Quarter 2008 Results 11Varian, Inc. Reports First Quarter 2008 Results 12Varian, Inc. Reports First Quarter 2008 Results 13Varian, Inc. Reports First Quarter 2008 Results 14Varian, Inc. Reports First Quarter 2008 Results 15Varian, Inc. Reports First Quarter 2008 Results 16Varian, Inc. Reports First Quarter 2008 Results 17Varian, Inc. Reports First Quarter 2008 Results 18PPD Expands Global Central Lab Services into China 2PPD Expands Global Central Lab Services into China 3Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 2Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 3Sharps Compliance Corp. Announces Purchase of Medical Waste Disposal Facility and Addition of Autoclave Technology 4
(Date:7/24/2014)... brewery has its own microbial terroir, meaning the microbial ... found in the product, creating the final flavor according ... Applied and Environmental Microbiology . This is the ... a sake brewery. , Many sake makers inoculate ... A. Mills of the University of California, Davis, but ...
(Date:7/24/2014)... Einstein College of Medicine of Yeshiva University have ... for Parkinson,s Research to translate a basic science finding ... project will test chemical compounds on a newly identified ... acts on an underlying cause of the disease. ... manage their symptoms, we are eager to stop or ...
(Date:7/24/2014)... affect the connections between nerve cells and influence the ... of the brain that plays a significant role in ... of the study have been published in the journal ... active communication between nerve cells, known as neurons. For ... network where they constantly relay signals to one another. ...
Breaking Biology News(10 mins):The microbes make the sake brewery 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4
... scientists from the University of Leicester has published research which ... babies are being exposed to. Research published today ... Edition of Archives of Disease in Childhood documents ... premature infants as part of their medical care. The ...
... technological centre specialising in marine and food research, ... Third country eXpertise) project. The fundamental aim of ... possible on scientific fishery research programs from the ... to achieve effective coordination and cooperation between countries, ...
... suggests that human male fertility is impacted by long-term ... present in the male reproductive tract, further suggesting a ... genetic test to clarify mechanisms. Now, in a paper ... characterize the phenotype of mice genetically lacking FAAH, fatty ...
Cached Biology News:Research exposes the risk to infants from the chemicals used in liquid medicines 2Research exposes the risk to infants from the chemicals used in liquid medicines 3TXOTX, coordinated international project to contribute to sustainability of the marine resources 2February 2009 highlights from Biology of Reproduction 2
Curcumin is an extract of turmeric root with antioxidant, anti-tumor promoter, and anti-inflammatory properties. Curcumin inhibits the induction of NOS in macrophages....
UGT1A6 (D-20)...
... smallest electronic pressure controller available measuring 26 ... this unit specifically for the analytical instrumentation ... carrier gas flow control, microfluidic flow control, ... focusing, the OEM-EPC offers external pressure sensor ...
... The P5T Series Short Stroke Thrust ... stroke applications where mounting envelopes are limited ... wear bands and internal bumpers provide millions ... applications., Choice of composite bushings or ...
Biology Products: